Author

M DESMET

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), SGS (Belgium)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), SGS (Belgium)

OpenAlex ID: A5110178495

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses

2005 · G HERMAN, C STEVENS, et al. · Clinical Pharmacology & Therapeutics · 517

Works count: 1

Citation count: 517

H-index: 1

I10-index: 1